Article PDF
References
Kon V, Jabs K : Angiotensin in atherosclerosis. Curr Opin Nephrol Hypertens 2004; 13: 291–297.
Ferrario CM, Strawn WB : Role of the renin-angiotensinaldosterone system and proinflammatory mediators in cardiovascular disease. Am J Cardiol 2006; 98: 121–128.
Kanome T, Watanabe T, Nishio K, Takahashi K, Hongo S, Miyazaki A : Angiotensin II upregulates acyl-CoA:cholesterol acyltransferase-1 via angiotensin II type 1 receptor in human monocyte-macrophages. Hypertens Res 2008; 31: 1801–1810.
Tardif JC, Grégoire J, L'Allier PL, et al: Effects of the acyl coenzyme A:cholesterol acyltransferase inhibitor avasimibe on human atherosclerotic lesions. Circulation 2004; 110: 3372–3377.
Nissen SE, Tuzcu EM, Brewer HB, et al: Effect of ACAT inhibition on the progression of coronary atherosclerosis. N Engl J Med 2006; 354: 1253–1263.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shimosawa, T. Crosss Talk among Substances Can Answer Questions Raised by Clinical Trials. Hypertens Res 31, 1679–1680 (2008). https://doi.org/10.1291/hypres.31.1679
Received:
Issue Date:
DOI: https://doi.org/10.1291/hypres.31.1679